Stay updated on Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Two screenshots show the same page with no changes to the study details, eligibility criteria, or outcomes; any detected differences appear to be minor formatting adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T20:37:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Lung cancer and MedlinePlus Genetics related topics were added to the Study Details page.
    Difference
    0.1%
    Check dated 2025-10-27T14:09:30.000Z thumbnail image
  3. Check
    28 days ago
    Change Detected
    Summary
    Additions introduce a MedlinePlus Genetics topic on lung cancer; no deletions were found. This expands the page to cover genetic aspects of lung cancer.
    Difference
    0.2%
    Check dated 2025-10-13T07:19:30.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    3%
    Check dated 2025-10-06T04:27:02.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page updates the revision from v3.0.2 to v3.1.0, marking an iteration in the software or document without additional content changes.
    Difference
    0.1%
    Check dated 2025-09-29T00:00:32.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision bumped to v3.0.2; removed v3.0.1, Back to Top, and the Lung cancer related topic. Overall, a minor maintenance update with no impact on core content or functionality.
    Difference
    0.4%
    Check dated 2025-09-14T18:46:36.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.